{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:04:05Z","timestamp":1785333845684,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M751395"],"award-info":[{"award-number":["2024M751395"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007956","name":"Nanjing University of Chinese Medicine","doi-asserted-by":"publisher","award":["XPT82204443"],"award-info":[{"award-number":["XPT82204443"]}],"id":[{"id":"10.13039\/501100007956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002418","name":"Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences and Peking Union Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["Z2021064"],"award-info":[{"award-number":["Z2021064"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574638"],"award-info":[{"award-number":["82574638"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204443"],"award-info":[{"award-number":["82204443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004433","name":"Chinese Pharmaceutical Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004433","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.apsb.2025.12.039","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T07:23:27Z","timestamp":1766993007000},"page":"1449-1465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inhibition of PGK1 enhances sensitivity to tyrosine kinase inhibitor in T315I-mutant leukemia"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7867-3620","authenticated-orcid":false,"given":"Huijing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenlong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonghui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6422-5159","authenticated-orcid":false,"given":"Xiaoxuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2025.12.039_bib1","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood.V112.11.1095.1095","article-title":"Dasatinib-associated major molecular responses are rapidly achieved in patients with chronic myeloid leukemia in chronic phase (CML-CP) following resistance, suboptimal response, or intolerance on imatinib","volume":"112","author":"Hochhaus","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2025.12.039_bib2","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1021\/jm301581y","article-title":"Identification of GZD824 as an orally bioavailable inhibitor that targets phosphorylated and nonphosphorylated breakpoint cluster region-Abelson (Bcr-Abl) kinase and overcomes clinically acquired mutation-induced resistance against imatinib","volume":"56","author":"Ren","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.12.039_bib3","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1158\/1538-7445.AM2015-5389","article-title":"Abstract 5389: novel kinase inhibitor for imatinib-resistant chronic myeloid leukemia with T315I mutation","volume":"75","author":"Hong","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2025.12.039_bib4","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/leu.2010.71","article-title":"Erratum: six-Year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia","volume":"24","author":"Hochhaus","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.apsb.2025.12.039_bib5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/bloodadvances.2019000268","article-title":"Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemia","volume":"4","author":"Chan","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.apsb.2025.12.039_bib6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1182\/hematology.2023000446","article-title":"Accelerated-phase CML: de novo and transformed","volume":"2023","author":"Shanmuganathan","year":"2023","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.apsb.2025.12.039_bib7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/cbdd.13801","article-title":"Recent advances in bcr-abl tyrosine kinase inhibitors for overriding T315I mutation","volume":"97","author":"Liu","year":"2021","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.apsb.2025.12.039_bib8","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1158\/1078-0432.CCR-08-0117","article-title":"Therapeutic options against BCR-ABL1 T315I-positive chronic myelogenous leukemia","volume":"14","author":"Quintas-Cardama","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2025.12.039_bib9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/326501a0","article-title":"Human testis-specific PGK gene lacks introns and possesses characteristics of a processed gene","volume":"326","author":"Mccarrey","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.12.039_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41467-019-13601-8","article-title":"O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth","volume":"11","author":"Nie","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.12.039_bib11","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1136\/gutjnl-2018-317163","article-title":"Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer","volume":"69","author":"Liang","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2025.12.039_bib12","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1016\/j.apsb.2022.05.012","article-title":"A potent PGK1 antagonist reveals PGK1 regulates the production of IL-1\u03b2 and IL-6","volume":"12","author":"Liao","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.12.039_bib13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2796.2011.02427.x","article-title":"The human protein atlas as a proteomic resource for biomarker discovery","volume":"270","author":"Pont\u00e9n","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.apsb.2025.12.039_bib14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.molcel.2016.02.009","article-title":"Mitochondria-translocated PGK1 functions as a protein kinase to coordinate glycolysis and the TCA cycle in tumorigenesis","volume":"61","author":"Li","year":"2016","journal-title":"Mol Cells"},{"key":"10.1016\/j.apsb.2025.12.039_bib15","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1007\/s13577-023-00919-1","article-title":"HDAC inhibitor chidamide overcomes drug resistance in chronic myeloid leukemia with the T315i mutation through the Akt-autophagy pathway","volume":"36","author":"Le","year":"2023","journal-title":"Hum Cell"},{"key":"10.1016\/j.apsb.2025.12.039_bib16","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.62347\/RWLJ3990","article-title":"mTOR inhibition by AZD2014 alleviates BCR::ABL1 independent imatinib resistance through enhancing autophagy in CML resistant cells","volume":"14","author":"He","year":"2024","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.apsb.2025.12.039_bib17","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/ph16040586","article-title":"Betulinic acid\u2013brosimine B hybrid compound has a synergistic effect with imatinib in chronic myeloid leukemia cell line, modulating apoptosis and autophagy","volume":"16","author":"Willig","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.apsb.2025.12.039_bib18","first-page":"3877","article-title":"The VCP\/p97 system at a glance: connecting cellular function to disease pathogenesis","volume":"127","author":"Meyer","year":"2014","journal-title":"J Cell Sci"},{"key":"10.1016\/j.apsb.2025.12.039_bib19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.gene.2016.02.042","article-title":"Structure and function of the AAA+ ATPase p97\/Cdc48p","volume":"583","author":"Xia","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.apsb.2025.12.039_bib20","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019102361","article-title":"The p97\u2013Ataxin 3 complex regulates homeostasis of the DNA damage response E3 ubiquitin ligase RNF 8","volume":"38","author":"Singh","year":"2019","journal-title":"EMBO J"},{"key":"10.1016\/j.apsb.2025.12.039_bib21","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1080\/15548627.2021.1898742","article-title":"VCP\/p97 modulates PtdIns3P production and autophagy initiation","volume":"17","author":"Wrobel","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2025.12.039_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00154-18","article-title":"The VCP\u2013UBXN1 complex mediates triage of ubiquitylated cytosolic proteins bound to the BAG6 complex","volume":"38","author":"Ganji","year":"2018","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.apsb.2025.12.039_bib23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1083\/jcb.200908115","article-title":"Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease","volume":"187","author":"Ju","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2025.12.039_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13041-016-0212-8","article-title":"Valosin-containing protein is a key mediator between autophagic cell death and apoptosis in adult hippocampal neural stem cells following insulin withdrawal","volume":"9","author":"Yeo","year":"2016","journal-title":"Mol Brain"},{"key":"10.1016\/j.apsb.2025.12.039_bib25","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1002\/stem.2082","article-title":"Calpain determines the propensity of adult hippocampal neural stem cells to autophagic cell death following insulin withdrawal","volume":"33","author":"Chung","year":"2015","journal-title":"Stem Cell"},{"key":"10.1016\/j.apsb.2025.12.039_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.154","article-title":"Natural HDAC-1\/8 inhibitor baicalein exerts therapeutic effect in CBF-AML","volume":"10","author":"Yu","year":"2020","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.apsb.2025.12.039_bib27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.stem.2015.08.004","article-title":"HDAC8 inhibition specifically targets Inv(16) acute myeloid leukemic stem cells by restoring p53 acetylation","volume":"17","author":"Qi","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.apsb.2025.12.039_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12943-018-0791-3","article-title":"Pyruvate kinase M2 fuels multiple aspects of cancer cells: from cellular metabolism, transcriptional regulation to extracellular signaling","volume":"17","author":"Hsu","year":"2018","journal-title":"Mol Cancer"},{"key":"10.1016\/j.apsb.2025.12.039_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41419-022-04499-0","article-title":"PGK1 represses autophagy-mediated cell death to promote the proliferation of liver cancer cells by phosphorylating PRAS40","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2025.12.039_bib30","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/s41418-022-01000-4","article-title":"The phosphorylation and dephosphorylation switch of VCP\/p97 regulates the architecture of centrosome and spindle","volume":"29","author":"Zhu","year":"2022","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.apsb.2025.12.039_bib31","doi-asserted-by":"crossref","first-page":"11435","DOI":"10.1016\/S0021-9258(19)78142-3","article-title":"Biochemical characterization of valosin-containing protein, a protein tyrosine kinase substrate in hematopoietic cells","volume":"269","author":"Egerton","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2025.12.039_bib32","doi-asserted-by":"crossref","first-page":"17806","DOI":"10.1074\/jbc.274.25.17806","article-title":"Identification of the cell cycle regulator VCP (p97\/CDC48) as a substrate of the band 4.1-related protein-tyrosine phosphatase PTPH1","volume":"274","author":"Zhang","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2025.12.039_bib33","doi-asserted-by":"crossref","first-page":"31870","DOI":"10.1074\/jbc.M501802200","article-title":"Akt-mediated valosin-containing protein 97 phosphorylation regulates its association with ubiquitinated proteins","volume":"280","author":"Klein","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2025.12.039_bib34","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/s13058-014-0437-3","article-title":"Profiling the tyrosine phosphoproteome of different mouse mammary tumour models reveals distinct, model-specific signalling networks and conserved oncogenic pathways","volume":"16","author":"Ali","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.apsb.2025.12.039_bib35","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1073\/pnas.0609836104","article-title":"Large-scale phosphorylation analysis of mouse liver","volume":"104","author":"Vill\u00e9n","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2025.12.039_bib36","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2443.2009.01286.x","article-title":"p97\/valosin-containing protein (VCP) is highly modulated by phosphorylation and acetylation","volume":"14","author":"Mori-Konya","year":"2009","journal-title":"Genes Cells"},{"key":"10.1016\/j.apsb.2025.12.039_bib37","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/s41375-019-0700-9","article-title":"A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease","volume":"34","author":"Horne","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.apsb.2025.12.039_bib38","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1080\/15548627.2019.1596492","article-title":"GCA links TRAF6\u2013ULK1-dependent autophagy activation in resistant chronic myeloid leukemia","volume":"15","author":"Han","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2025.12.039_bib39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.biopha.2015.12.029","article-title":"Heme oxygenase-1 contributes to imatinib resistance by promoting autophagy in chronic myeloid leukemia through disrupting the mTOR signaling pathway","volume":"78","author":"Cao","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2025.12.039_bib40","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic myeloid leukemia","volume":"340","author":"Sawyers","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2025.12.039_bib41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ajh.23428","article-title":"Induction of autophagy by imatinib sequesters bcr-abl in autophagosomes and down-regulates bcr-abl protein","volume":"88","author":"Baukje","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.apsb.2025.12.039_bib42","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.apsb.2020.11.009","article-title":"Design, synthesis, and biological evaluation of bcr-abl PROTACs to overcome T315I mutation","volume":"11","author":"Jiang","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.12.039_bib43","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1182\/blood-2010-12-322537","article-title":"BCR-ABL suppresses autophagy through ATF5-mediated regulation of mTOR transcription","volume":"118","author":"Sheng","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2025.12.039_bib44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.tibs.2018.01.006","article-title":"Metabolic kinases moonlighting as protein kinases","volume":"43","author":"Lu","year":"2018","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.apsb.2025.12.039_bib45","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41420-022-00991-w","article-title":"Modulation of energy metabolism to overcome drug resistance in chronic myeloid leukemia cells through induction of autophagy","volume":"8","author":"Li","year":"2022","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.apsb.2025.12.039_bib46","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2318956121","article-title":"A model for stimulation of enzyme activity by a competitive inhibitor based on the interaction of terazosin and phosphoglycerate kinase 1","volume":"121","author":"Riley","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2025.12.039_bib47","article-title":"Novel inhibitors targeting the PGK1 metabolic enzyme in glycolysis exhibit effective antitumor activity against kidney renal clear cell carcinoma in vitro and in vivo. Eur J Med Chem","volume":"267","author":"He","year":"2024"},{"key":"10.1016\/j.apsb.2025.12.039_bib48","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/s41598-024-84802-5","article-title":"Identification of new reference genes with stable expression patterns for cell cycle experiments in human leukemia cell lines","volume":"15","author":"T\u00f3th","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2025.12.039_bib49","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41417-025-00913-9","article-title":"Retraction note: nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4","volume":"32","author":"Hu","year":"2025","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.apsb.2025.12.039_bib50","article-title":"Caspase family in autoimmune diseases","volume":"24","author":"Zhang","year":"2024","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.apsb.2025.12.039_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113311","article-title":"Bortezomib induces cell apoptosis and increases the efficacy of \u03b1PD-1 in BCR::ABL T315I mutation CML by targeting UBE2Q1","volume":"143","author":"Jiang","year":"2024","journal-title":"Int immunopharmacol"},{"key":"10.1016\/j.apsb.2025.12.039_bib52","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/s41467-024-45471-0","article-title":"Leukaemia exposure alters the transcriptional profile and function of BCR::ABL1 negative macrophages in the bone marrow niche","volume":"15","author":"Dawson","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.12.039_bib53","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00277-016-2915-4","article-title":"Programmed cell death-1 pathway inhibition in myeloid malignancies: implications for myeloproliferative neoplasms","volume":"96","author":"Choi","year":"2017","journal-title":"Ann Hematol"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525008470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525008470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T19:50:56Z","timestamp":1776196256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383525008470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2211383525008470"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2025.12.039","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of PGK1 enhances sensitivity to tyrosine kinase inhibitor in T315I-mutant leukemia","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2025.12.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}